Department of Surgical Oncology, Emory University, Atlanta, Georgia.
JAMA Surg. 2013 Aug;148(8):769-77. doi: 10.1001/jamasurg.2013.2136.
The circumferential resection margin is the primary determinant of local recurrence and a major factor in survival in rectal cancer. Neither chemotherapy nor chemoradiation compensates for a margin positive for cancer.
To identify treatment-related factors associated with hospital margin-positive resection and to develop a tool that could be used by individual hospitals to assess their outcomes based on their unique mix of patient and tumor characteristics.
Retrospective review of the National Cancer Data Base, 1998-2007.
Community and academic/research hospitals.
Individuals with histologically confirmed localized rectal/rectosigmoid adenocarcinoma.
All individuals underwent radical resection for rectal cancer with or without neoadjuvant therapy.
Rate of margin positivity determined and adjusted for patient- and tumor-related factors to calculate expected margin positivity per hospital. An observed to expected ratio was calculated based on patient- and tumor-related factors to identify treatment-associated variation.
The overall margin-positive resection rate was 5.2%. Patients with margins positive for cancer were more likely to be older, male, and African American; not have private insurance; and have their cancer diagnosed later in the study period. Associated tumor-related factors include rectal location, higher American Joint Committee on Cancer stage, signet/mucinous histology, and poor/undifferentiated grade. Among hospitals that were significantly low outliers, 47% were comprehensive community hospitals, and 43.9% were academic/research hospitals; of those that were significantly high outliers, 52.3% were comprehensive community hospitals, and 17.8% were academic/research hospitals. High-volume centers made up 80% of significantly low outlier hospitals and 17% of significantly high outlier hospitals. The rates of chemotherapy and radiation were similar, but low outlier hospitals gave more neoadjuvant radiation (26.3% vs 17%).
After adjustment for patient- and tumor-related factors, we identified both low and high outlier hospitals for margin positivity at resection, as well as potentially modifiable risk factors. The nomogram created in this model allows for the evaluation of observed and expected event rates for individual hospitals, providing a hospital self-assessment tool for identifying targets for improvement.
环周切缘是局部复发的主要决定因素,也是直肠癌生存的主要因素。化疗和放化疗都不能弥补癌症阳性切缘。
确定与医院切缘阳性相关的治疗相关因素,并开发一种工具,使各医院能够根据其独特的患者和肿瘤特征组合,评估其结果。
对 1998 年至 2007 年全国癌症数据库进行回顾性分析。
社区和学术/研究医院。
组织学证实的局部直肠/直肠乙状结肠癌患者。
所有患者均接受根治性直肠癌切除术,包括新辅助治疗。
确定并调整与患者和肿瘤相关的因素,以计算每个医院的预期切缘阳性率。根据患者和肿瘤相关因素计算观察到的与预期的比值,以确定与治疗相关的差异。
总的切缘阳性切除率为 5.2%。癌症切缘阳性的患者更可能年龄较大、男性、非裔美国人;没有私人保险;并且在研究期间癌症诊断较晚。相关肿瘤相关因素包括直肠位置、较高的美国癌症联合委员会分期、印戒/黏液组织学和差/未分化分级。在显著低值异常的医院中,47%为综合性社区医院,43.9%为学术/研究医院;在显著高值异常的医院中,52.3%为综合性社区医院,17.8%为学术/研究医院。高容量中心占显著低值异常医院的 80%和显著高值异常医院的 17%。化疗和放疗的比例相似,但低值异常医院给予更多的新辅助放疗(26.3%比 17%)。
在调整了患者和肿瘤相关因素后,我们确定了切缘阳性的低和高异常值医院,以及潜在的可改变的危险因素。该模型中创建的列线图允许对个别医院的观察和预期事件率进行评估,为医院提供了自我评估工具,以确定改进的目标。